11.20.2018
Diagnostics
$2,273,245.00
55 months
Development and validation of an epigenetic biomarker that predicts treatment success and allows personalized management in Crohn's disease
Funding to identify epigenetic biomarkers that will allow for better personalized treatment of Crohn's disease patients.